- SCSK maintains its forecast for fiscal year operating income at 66.50 billion yen, surpassing the market estimate of 63.86 billion yen.
- The company expects net income to remain at 46.50 billion yen, higher than the estimated 45.1 billion yen.
- SCSK projects its net sales to be 596.00 billion yen, which is significantly above the forecasted 543.36 billion yen.
- The dividend per share is anticipated to be 71.00 yen, slightly above the estimate of 70.22 yen.
- Market sentiment appears positive with 7 buy recommendations, 5 holds, and no sell recommendations for SCSK.
- All estimates and comparisons to past results are based on the company’s original disclosures.
A look at Scsk Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Scsk Corp, a provider of IT services, has a solid long-term outlook as indicated by its Smartkarma Smart Scores. With a strong momentum score of 5, the company shows promising growth potential in the future. Additionally, Scsk Corp has respectable scores of 3 in both Dividend and Growth, reflecting steady performance and a focus on expansion. However, there is room for improvement in areas such as Value and Resilience, with scores of 2 each.
SCSK Corporation, a leading IT services provider, is well-positioned in the market with a balanced performance across various factors. While the company demonstrates robust momentum, supported by its services and solutions, there are opportunities to enhance its value and resilience. With a strategic focus on growth and a stable dividend payout, Scsk Corp‘s overall outlook appears positive for long-term investors.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
